Abstract:
Patients with diabetes mellitus type 2 are a very heterogeneous group with varying degree of β-cells function and some of them may need insulin to correct hyperglycemia. In patients with second failure to sulfonylurea the treatment of insulin is an obvious therapeutic option.
